Quarterly report · Q1
3151.TEDINET S100OW8K
Period2022-04-01 → 2022-06-30
Filed2022-08-09
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥143.5bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥577.2bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥142.9bn | 2021-04-01 → 2021-06-30 | Cons. | Net sales |
| Operating income | ¥452m | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥377m | 2021-04-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | ¥1.2bn | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥5.8bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.1bn | 2021-04-01 → 2021-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.1bn | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.1bn | 2021-04-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥640m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥4.8bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥644m | 2021-04-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥675m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥674m | 2021-04-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥314.2bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥313.0bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥333.7bn | at 2021-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥212.9bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥213.0bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥101.4bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥100.0bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥106.1bn | at 2021-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥27.9bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥27.0bn | at 2022-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥12.05 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥87.88 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥11.67 | 2021-04-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 31.9% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.6% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.5% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 54
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-06-30 | ¥1.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-06-30 | ¥1.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥626m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-06-30 | −¥69m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥3.4bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥3.4bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | ¥0 |
| jpcrp040300-q1r_E22440-000Medicine Wholesalereportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥138.0bn |
| jpcrp040300-q1r_E22440-000Medicine Wholesalereportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥135.2bn |
| jpcrp040300-q1r_E22440-000Medicine Wholesalereportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥2.8bn |
| jpcrp040300-q1r_E22440-000Medicine Wholesalereportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥389m |
| jpcrp040300-q1r_E22440-000Pharmacy Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥4.5bn |
| jpcrp040300-q1r_E22440-000Pharmacy Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥4.5bn |
| jpcrp040300-q1r_E22440-000Pharmacy Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥0 |
| jpcrp040300-q1r_E22440-000Pharmacy Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥14m |
| jpcrp040300-q1r_E22440-000Veterinary Drugs Wholesale Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥2.7bn |
| jpcrp040300-q1r_E22440-000Veterinary Drugs Wholesale Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥2.7bn |
| jpcrp040300-q1r_E22440-000Veterinary Drugs Wholesale Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥0 |
| jpcrp040300-q1r_E22440-000Veterinary Drugs Wholesale Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥118m |
| —segment total | revenue | 2022-04-01 → 2022-06-30 | ¥145.1bn |
| —segment total | revenue external | 2022-04-01 → 2022-06-30 | ¥142.3bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥2.8bn |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | ¥521m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-06-30 | ¥146.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-06-30 | ¥143.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥3.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-06-30 | ¥452m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2021-06-30 | ¥1.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2021-06-30 | ¥1.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥626m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-06-30 | −¥45m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-06-30 | −¥2.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-06-30 | −¥2.8bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-06-30 | −¥13m |
| jpcrp040300-q1r_E22440-000Medicine Wholesalereportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥137.0bn |
| jpcrp040300-q1r_E22440-000Medicine Wholesalereportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥134.8bn |
| jpcrp040300-q1r_E22440-000Medicine Wholesalereportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥2.2bn |
| jpcrp040300-q1r_E22440-000Medicine Wholesalereportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥290m |
| jpcrp040300-q1r_E22440-000Pharmacy Businessreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥4.4bn |
| jpcrp040300-q1r_E22440-000Pharmacy Businessreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥4.4bn |
| jpcrp040300-q1r_E22440-000Pharmacy Businessreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥1m |
| jpcrp040300-q1r_E22440-000Pharmacy Businessreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥39m |
| jpcrp040300-q1r_E22440-000Veterinary Drugs Wholesale Businessreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥2.6bn |
| jpcrp040300-q1r_E22440-000Veterinary Drugs Wholesale Businessreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥2.6bn |
| jpcrp040300-q1r_E22440-000Veterinary Drugs Wholesale Businessreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥0 |
| jpcrp040300-q1r_E22440-000Veterinary Drugs Wholesale Businessreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥106m |
| —segment total | revenue | 2021-04-01 → 2021-06-30 | ¥144.0bn |
| —segment total | revenue external | 2021-04-01 → 2021-06-30 | ¥141.8bn |
| —segment total | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥2.2bn |
| —segment total | segment profit | 2021-04-01 → 2021-06-30 | ¥437m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-06-30 | ¥145.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-06-30 | ¥142.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥2.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-06-30 | ¥391m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 370
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)有限責任監査法人トーマツ | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)後 藤 英 俊 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)福 士 直 和 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 142916000000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 143521000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 577249000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 1067000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 1198000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 5834000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 644000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 640000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 4770000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 2228000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 3068000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | -1663000000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 106090000000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 101361000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 100041000000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 333676000000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 314221000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 313033000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 11.67 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 12.05 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 87.88 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.315 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.319 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.316 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 61224796 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 61224796 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 61224796 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 61224796 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 7866400 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 53307800 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 533078 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 50596 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 61224796 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 533078 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 7866400 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 7866400 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.1285 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |